Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 5
2015 16
2016 16
2017 17
2018 16
2019 23
2020 12
2021 4
2022 7
2023 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 33288564

99 results
Results by year
Filters applied: . Clear all
Page 1
Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.
Kanda M, Nomoto S, Oya H, Hashimoto R, Takami H, Shimizu D, Sonohara F, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Murotani K, Fujiwara M, Kodera Y. Kanda M, et al. J Exp Clin Cancer Res. 2014 Oct 22;33(1):88. doi: 10.1186/s13046-014-0088-3. J Exp Clin Cancer Res. 2014. PMID: 25330808 Free PMC article.
Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer.
Kanda M, Nomoto S, Oya H, Shimizu D, Takami H, Hibino S, Hashimoto R, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Kanda M, et al. J Exp Clin Cancer Res. 2014 Aug 6;33(1):66. doi: 10.1186/s13046-014-0066-9. J Exp Clin Cancer Res. 2014. PMID: 25096402 Free PMC article.
STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer.
Nakamura S, Kanda M, Shimizu D, Sawaki K, Tanaka C, Hattori N, Hayashi M, Yamada S, Nakayama G, Omae K, Koike M, Kodera Y. Nakamura S, et al. Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):509-516. doi: 10.21873/cgp.20207. Cancer Genomics Proteomics. 2020. PMID: 32859629 Free PMC article.
PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer.
Baba H, Kanda M, Sawaki K, Umeda S, Miwa T, Shimizu D, Tanaka C, Kobayashi D, Fujiwara M, Kodera Y, Fujii T. Baba H, et al. Ann Surg Oncol. 2020 Jun;27(6):2071-2080. doi: 10.1245/s10434-019-07985-6. Epub 2019 Oct 28. Ann Surg Oncol. 2020. PMID: 31659640
Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
Kanda M, Shimizu D, Tanaka H, Shibata M, Iwata N, Hayashi M, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Kanda M, et al. Oncotarget. 2016 Mar 22;7(12):13667-79. doi: 10.18632/oncotarget.7269. Oncotarget. 2016. PMID: 26872374 Free PMC article.
99 results